Company Filing History:
3 out of 3 
2 out of 1,777 
Years Active: 2016-2021
Title: Spotlight on Inventor Maartje Van Den Biggelaar: Pioneering Innovations in Coagulation Factors
Introduction: Maartje Van Den Biggelaar, a renowned inventor based in Amsterdam, NL, is making waves in the field of coagulation factors with his groundbreaking inventions. With a total of 3 patents to his name, Maartje's contributions are shaping the future of modified Factor VIII molecules with decreased cellular uptake.
Latest Patents: One of Maartje's latest patents includes "Factor VIII variants having a decreased cellular uptake," where he delves into the realm of modified coagulation factors. By creating innovative Factor VIII molecules with reduced cellular uptake, Maartje is revolutionizing the landscape of coagulation therapies.
Career Highlights: Throughout his illustrious career, Maartje has showcased his expertise in companies such as Sanquin Blood Supply Foundation and Novo Nordisk A/S. His dynamic approach to innovation has led to significant advancements in the field of hematology and coagulation research.
Collaborations: Maartje has had the privilege of working alongside esteemed colleagues such as Henriet Meems and Alexander Benjamin Meijer. Together, they have synergized their efforts to push the boundaries of coagulation factor research, resulting in impactful discoveries that benefit patients worldwide.
Conclusion: In conclusion, Maartje Van Den Biggelaar's dedication to pioneering innovations in coagulation factors has cemented his legacy as a visionary inventor. His extraordinary contributions continue to shape the future of hematology, promising enhanced therapies for individuals in need.